The most positively correlated medications that induced disease gene signatures included orlistat, a lipase inhibitor used for weight loss and T2D, had the greatest coefficient of 0.3104 (LIPF, PNLIP, DAGLA, and FASN targets). The gene discussed is DAGLA; the disease is type 2 diabetes mellitus.